Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9890156 Bicyclic heterocycles as FGFR4 inhibitors

Patent 9890156 was granted and assigned to Incyte on February, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ding-Quan Qian0

Liang Lu0

Liangxing Wu0

Wenqing Yao0

Date of Patent

February 13, 2018

0

Patent Application Number

150478760

Date Filed

February 19, 2016

0

Patent Citations Received

US Patent 11667635 Bicyclic heterocycles as FGFR4 inhibitors

0

US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent

0

US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors

0

US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 12024517 Salts of an FGFR inhibitor

0

US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors

0

US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors

0

Patent Primary Examiner

Leslie A. Royds Draper

0

Patent abstract

The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9890156 Bicyclic heterocycles as FGFR4 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool